US 11,925,624 B2
Methods of administering anti-fibrotic therapy
Lin Pan, San Francisco, CA (US); Dorothy Sze-Wing Cheung, San Francisco, CA (US); Jeffrey Mark Harris, San Francsico, CA (US); and Indiana Strombom, San Francisco, CA (US)
Assigned to GENENTECH, INC., South San Francisco, CA (US)
Filed by GENENTECH, INC., South San Francisco, CA (US)
Filed on Nov. 17, 2021, as Appl. No. 17/528,537.
Application 17/528,537 is a division of application No. 16/465,015, granted, now 11,207,304, previously published as PCT/US2017/063549, filed on Nov. 29, 2017.
Claims priority of provisional application 62/432,425, filed on Dec. 9, 2016.
Claims priority of provisional application 62/428,163, filed on Nov. 30, 2016.
Prior Publication US 2022/0184046 A1, Jun. 16, 2022
Int. Cl. A61K 31/4439 (2006.01); A61K 31/437 (2006.01)
CPC A61K 31/437 (2013.01) [A61K 31/4439 (2013.01)] 12 Claims
OG exemplary drawing
 
1. A method of providing Compound I therapy to a subject in need thereof:

OG Complex Work Unit Chemistry
comprising:
evaluating the renal function of the subject; and then
administering a therapeutically effective amount of Compound I to the subject.